Metformin attenuates mechanistic target of rapamycin complex 1/hypoxia-inducible factor-1α-driven glycolysis reducing keratinocyte and T helper 17 cell proliferation in hyperproliferative inflammatory skin diseases
British Journal of Dermatology · 2023
DOI: 10.1093/bjd/ljad362 ↗Kurz gefasst
Editorial in der Zeitschrift British Journal of Dermatology, 2023. Verfasst von Bodo C Melnik. Beteiligte Einrichtung: Department of Dermatology, Environmental Medicine and Health Theory, University of Osnabrück, Osnabrück, Germany. Hauptthemen laut MEDLINE: Metformin, Hidradenitis Suppurativa. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 10 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Dermatology, Environmental Medicine and Health Theory, University of Osnabrück, Osnabrück, Germany.
ORCID-Profile: Bodo C Melnik
Zitieren
APA
Melnik, B. C. (2023). Metformin attenuates mechanistic target of rapamycin complex 1/hypoxia-inducible factor-1α-driven glycolysis reducing keratinocyte and T helper 17 cell proliferation in hyperproliferative inflammatory skin diseases. British Journal of Dermatology. https://doi.org/10.1093/bjd/ljad362
Vancouver
Melnik BC. Metformin attenuates mechanistic target of rapamycin complex 1/hypoxia-inducible factor-1α-driven glycolysis reducing keratinocyte and T helper 17 cell proliferation in hyperproliferative inflammatory skin diseases. British Journal of Dermatology. 2023. doi:10.1093/bjd/ljad362
BibTeX
@article{Melnik2023,
author = {Melnik, Bodo C},
title = {Metformin attenuates mechanistic target of rapamycin complex 1/hypoxia-inducible factor-1α-driven glycolysis reducing keratinocyte and T helper 17 cell proliferation in hyperproliferative inflammatory skin diseases},
journal = {British Journal of Dermatology},
year = {2023},
doi = {10.1093/bjd/ljad362}
}
EUVIMED